DoW Melanoma Research Program Team Science Award
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The FY26 Melanoma Research Program Team Science Award aims to support multidisciplinary, hypothesis-driven research projects focused on advancing knowledge and improving patient care in melanoma. This award encourages collaboration between at least two and up to three principal investigators, ideally from multiple institutions, to jointly design and execute a single research project. While collaborating with the melanoma patient community is encouraged to enhance the practical impact of the research, it is not mandatory. Applicants must first submit a pre-application, and only those invited may proceed to submit full applications, with all designated principal investigators required to participate in the submission process. The program expects to allocate approximately $18.9 million to fund around nine awards, each capped at $2.1 million in total costs, with a maximum performance period of three years. Awards will be funded using FY26 appropriations, which must be expended by September 30, 2032, with all awards awarded no later than September 30, 2027. The funding is managed by the Department of Defense through the Congressionally Directed Medical Research Programs, with support and inquiries handled via the eBRAP help desk.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Team Science Award supports a broad range of hypothesis-driven, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex, multi-dimensional problems that will impact patient outcomes.
Distinctive Features:
· This funding mechanism requires multiple Principal Investigators (PIs). At least two and up to three PIs should partner to jointly design and execute a single research project; multi-institutional partnerships are encouraged. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).
· Consumer Collaboration Option: Investigators are encouraged, but not required, to form collaborative relationships with the melanoma consumer community to maximize the impact and translatability of the research for the benefit of the intended community(ies).
· After submitting the required pre-application, investigators must receive an invitation to submit a full application.
○ Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research effort.
Funding Details: The Congressionally Directed Medical Research Programs expects to allot roughly $18.9M to fund approximately nine Team Science Award applications with total cost caps of $2.1M per award. The maximum period of performance is 3 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
https://cdmrp.health.mil/pubs/press/2026/mrppreann
